Document is current
Any future updates will be listed below
-
Authors
Redmond, H. Paul
Neary, Peter M.
Jinih, Marcel
O’Connell, Emer
Foley, Niamh
Pfirrmann, Rolf W.
Wang, Jiang H.
O’Leary, D. Peter https://orcid.org/0000-0003-3701-4249
-
Funding
Funding for this research was provided by:
Geistlich Pharma
- License Information
-
More Information
Article History
Received: 19 February 2018
Accepted: 27 June 2018
First Online: 6 August 2018
Ethics approval and consent to participate
: Trial participation was approved in all 3 study sites by the Cork Research Ethics Committee and the Irish Medicines Board and was registered with EudraCT (registration number = 2008–005570-12) and ISRCTN (registration number = 77,829,558). Written consent to participate was given by each patient.
: Participating patients gave full written informed consent to allow for patient data to be included in any subsequent publication.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
